The Prevalence of Diabetic Retinopathy Among Adults in the United States

Abstract

The Eye Diseases Prevalence Research Group* Objective: To determine the prevalence of diabetic retinopathy among adults 40 years and older in the United States. Methods: Pooled analysis of data from 8 populationbased eye surveys was used to estimate the prevalence, among persons with diabetes mellitus (DM), of retinopathy and of vision-threatening retinopathy-defined as proliferative or severe nonproliferative retinopathy and/or macular edema. Within strata of age, race/ethnicity, and gender, US prevalence rates were estimated by multiplying these values by the prevalence of DM reported in the 1999 National Health Interview Survey and the 2000 US Census population. Results: Among an estimated 10.2 million US adults 40 years and older known to have DM, the estimated crude prevalence rates for retinopathy and vision-threatening retinopathy were 40.3% and 8.2%, respectively. The estimated US general population prevalence rates for retinopathy and vision-threatening retinopathy were 3.4% (4.1 million persons) and 0.75% (899000 persons). Future projections suggest that diabetic retinopathy will increase as a public health problem, both with aging of the US population and increasing age-specific prevalence of DM over time. Conclusion: Approximately 4.1 million US adults 40 years and older have diabetic retinopathy; 1 of every 12 persons with DM in this age group has advanced, visionthreatening retinopathy.

An observational study to assess if automated diabetic retinopathy image assessment software can replace one or more steps of manual imaging grading and to determine their cost-effectiveness

“…5 The characteristic lesions of diabetic retinopathy are presently estimated to affect nearly half of those diagnosed at any given time. [6][7][8][9] The advances in the medical management of diabetes mellitus have substantially increased patient survival and life expectancy. However, in doing so people with diabetes mellitus are placed at an increased risk for developing diabetes mellitus-related microvascular complications, the most common of which is diabetic retinopathy.…”

The Status of Diabetic Retinopathy and Diabetic Macular Edema in Patients with Type 2 Diabetes: A Survey from Beixinjing District of Shanghai City in China

“…It was 2.0% in the 30–44 age group, 8.0% in the 45–59 age group and 14.2% above 60 years [2]. Pooled data from 8 population-based studies demonstrated that among an estimated 10.2 million adults 40 years or older known to have diabetes mellitus in the USA, the estimated crude prevalence rate for retinopathy was 40.3% [3]. Diabetic macular edema (DME) was a primary cause of visual loss in diabetic patients.…”

Aflibercept treatment in patients with diabetic macular edema

“…но ДР является ведущей причиной инвалидности по зрению среди взрослых людей молодого и тру-доспособного возраста в развитых странах [24,41]. Тяжёлая потеря зрения может происходить вслед-ствие пролиферативной ДР, но наиболее распро-странённой причиной снижения зрения у этих больных является ДМО, который развивается почти у 12 % пациентов с ДР и ежегодно приво-дит к развитию слепоты у более чем 10 000 новых пациентов [27,36,40].…”

“…При наличии у пациента сахарного диабета в те-чение более 20 лет ДР выявляется практически у всех пациентов с диабетом 1-го типа и примерно у 80 % больных диабетом 2-го типа [24]. Имен-…”